Document is current
Any future updates will be listed below
-
Authors
van der Schans, Simon
Velikanova, Rimma
Weidlich, Diana
Howells, Ruth
Patel, Anish
Bischof, Matthias
Postma, Maarten J.
Boersma, Cornelis
-
Funding
Funding for this research was provided by:
Novartis Gene Therapies (N/A)
- License Information
-
More Information
Article History
Received: 9 November 2023
Accepted: 16 December 2024
First Online: 21 February 2025
Declarations
:
: This article is a cost comparison analysis and does not contain any new studies with human participants or animals performed by any of the authors.
: Matthias Bischof and Anish Patel are employees of Novartis Gene Therapies, Inc., and own Novartis stock or other equities. Cornelis Boersma and Maarten Postma have received grants from Novartis Gene Therapies, Inc. Diana Weidlich and Ruth Howells are employees of Clarivate, which received funding for this analysis from Novartis Gene Therapies. Simon van der Schans and Rimma Velikanova report no conflicts of interest.
